Biotechnology company demonstrates how strategic location selection can dramatically reduce development costs while maintaining scientific rigor In an industry where clinical trial costs can exceed $60 million and span multiple years, Dutch biotechnology company Celljevity is pioneering a revolutionary approach that could reshape how breakthrough therapies reach patients worldwide. The company’s strategic decision to conduct […]

Read More